Literature DB >> 18209980

[Role of mediastinoscopy and repeat mediastinoscopy today].

M Hinterthaner1, G Stamatis.   

Abstract

For patients with lung cancer preoperative evaluation of the mediastinal lymph nodes is important to estimate local operability and/or to consider the necessity of neoadjuvant treatment. Cervical mediastinoscopy is generally accepted as a safe and highly accurate procedure in the staging of lung cancer. Nodes accessible to CM are the levels of the superior (level 2R and 2L) and inferior (level 4R and 4L) paratracheal and subcarinal (level 7) nodal stations. Additionally extended CM and left parasternal mediastinotomy allow the exploration of the aortopulmonary window (level 5) and anterior mediastinal nodes (level 6). In locally advanced lung cancer repeat mediastinoscopy was used after induction chemotherapy or chemoradiation to reexplore the upper mediastinum in order to select patients with a higher probability to undergo complete resection. Operative mortality of both investigations is less than 0.5%; the preoperative complication rate is very low (less than 4%). Because of the higher sensitivity, specificity, and accuracy, mediastinoscopy and repeat mediastinoscopy are superior to new methods like FDG-PET, FDG-PET/CT, EBUS-FNA, and EUS-FNA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209980     DOI: 10.1007/s00104-007-1447-9

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  32 in total

1.  Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.

Authors:  Michael T Jaklitsch; James E Herndon; Malcolm M DeCamp; William G Richards; Parvesh Kumar; Mark J Krasna; Mark R Green; David J Sugarbaker
Journal:  J Surg Oncol       Date:  2006-12-01       Impact factor: 3.454

2.  Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.

Authors:  Shin-Ichi Takeda; Hajime Maeda; Tatsuya Okada; Toshihiko Yamaguchi; Masaru Nakagawa; Soichiro Yokota; Noriyoshi Sawabata; Mitsunori Ohta
Journal:  Eur J Cardiothorac Surg       Date:  2006-05-26       Impact factor: 4.191

3.  Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.

Authors:  Sung Shine Shim; Kyung Soo Lee; Byung-Tae Kim; Myung Jin Chung; Eun Jung Lee; Joungho Han; Joon Young Choi; O Jung Kwon; Young Mog Shim; Seonwoo Kim
Journal:  Radiology       Date:  2005-07-12       Impact factor: 11.105

4.  Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate.

Authors:  Anthony Lemaire; Ivana Nikolic; Thomas Petersen; Jack C Haney; Eric M Toloza; David H Harpole; Thomas A D'Amico; William R Burfeind
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

5.  Video-assisted mediastinoscopic lymphadenectomy (VAMLA).

Authors:  Biruta Witte; Martin Hürtgen
Journal:  J Thorac Oncol       Date:  2007-04       Impact factor: 15.609

6.  Remediastinoscopy after induction chemotherapy in non-small cell lung cancer.

Authors:  M Mateu-Navarro; R Rami-Porta; R Bastus-Piulats; L Cirera-Nogueras; G González-Pont
Journal:  Ann Thorac Surg       Date:  2000-08       Impact factor: 4.330

7.  Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.

Authors:  Robert James Cerfolio; Ayesha S Bryant; Mohamad A Eloubeidi
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

8.  A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer.

Authors:  Gonzalo V Gonzalez-Stawinski; Anthony Lemaire; Faisal Merchant; Elizabeth O'Halloran; R Edward Coleman; David H Harpole; Thomas A D'Amico
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

Review 9.  Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer.

Authors:  Bryan A Whitson; Shawn S Groth; Michael A Maddaus
Journal:  Ann Thorac Surg       Date:  2007-09       Impact factor: 4.330

Review 10.  Noninvasive staging of non-small cell lung cancer: a review of the current evidence.

Authors:  Eric M Toloza; Linda Harpole; Douglas C McCrory
Journal:  Chest       Date:  2003-01       Impact factor: 9.410

View more
  1 in total

Review 1.  Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening.

Authors:  Enole Boedeker; Godehard Friedel; Thorsten Walles
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.